Genomic Health Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced total revenue was USD 114.355 million compared to USD 101.258 million a year ago. Operating income was USD 19.046 million compared to USD 11.758 million a year ago. Net income was USD 18.694 million compared to USD 12.225 million a year ago. Basic earnings per share was USD 0.5 compared to USD 0.34 a year ago. Diluted earnings per share was USD 0.48 compared to USD 0.32 a year ago. For the nine months, total revenue was USD 337.264 million compared to USD 289.502 million a year ago. Operating income was USD 46.083 million compared to USD 14.470 million a year ago. Net income was USD 47.680 million compared to USD 16.767 million a year ago. Basic earnings per share was USD 1.29 compared to USD 0.47 a year ago. Diluted earnings per share was USD 1.23 compared to USD 0.45 a year ago.